Loading...
Lupin Stock Reaches 52-Week High After Six Months of Continuous Gains
LIVE TV
LOCAL
Tour
ENGLISH
For You
Entertainment
National
Sports
Markets
Business & Economy
Lifestyle
World
Astrology & Religion
Technology
Education & Jobs
Auto
Politics
Viral
Opinions
Loading more articles...
Home
Local
Live TV
Lupin Shares Soar to 52-Week High on Strong Q3, Biosimilar Pipeline
C
CNBC TV18
•
05-03-2026, 12:19
Lupin Shares Soar to 52-Week High on Strong Q3, Biosimilar Pipeline
•
Lupin shares hit a fresh 52-week high on Thursday, March 5, after six consecutive months of gains since September 2025.
•
The stock rose 11% this year, outperforming the Nifty Pharma index's 1.2% gain.
•
Q3 revenue surged 28% to ₹7,167 crore with margins expanding to 31.6%; US sales reached a record $350 million.
•
Company targets $1 billion in US sales this fiscal year and plans five biosimilar launches over the next five years.
•
Strategic focus includes India growth, CDMO foray, and M&A for specialty assets in US, Europe, and India.
Read Full Article on Cnbc in English
✦
More like this
✦
More like this
Lupin's Ankleshwar Facility Gets 2 US FDA Observations; Q3 Profit Up 37.5%
C
CNBC TV18
Nifty to hit 27,200, then drop below 22,000 before soaring to 32,000 by next year
N
News18
LIC Boosts Cipla Stake to 9.1% After Acquiring Over 2% in Three Months
C
CNBC TV18
5 Multibagger Stocks Soared: Force Motors, Cupid, Lumax Auto Lead 1-Year Gains
N
News18
Top Brokerage Picks: These 3 Stocks Could Soar Up To 78% – Buy Now!
C
CNBC Awaaz
L&T Tech Services Surges 13% Amid Market Slump, Hits Biggest Gain Since 2020
C
CNBC TV18
